Eletriptan: Side Effects, Uses & Monitoring
Eletriptan hydrobromide tablets are indicated for the acute treatment of migraine with or without aura in adults.
- Data source
- FDA labeling via NIH DailyMed (label f6dc0893…)
- Label version
- current
- Last reviewed
- 2026
Reported adverse reactions
Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.
No structured frequency data available in current labeling. Consult the official label.
Labeled uses (from FDA prescribing information)
Eletriptan hydrobromide tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use: Use only if a clear diagnosis of migraine has been established. If a patient has no response to the first migraine attack treated with eletriptan hydrobromide tablets, reconsider the diagnosis of migraine before eletriptan hydrobromide tablets are administered to treat any subsequent attacks. Eletriptan hydrobromide tablets are not intended for the prevention of migraine attacks. Safety and effectiveness of eletriptan hydrobromide tablets have not been established for cluster headache.
Conditions associated with Eletriptan in labeling
Frequently Asked Questions
What is Eletriptan used for?
FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.
What are the most commonly reported side effects of Eletriptan?
Current labeling for this ingredient does not include a structured frequency table that we can reproduce. Review the official label linked below.
Does Eletriptan require lab monitoring?
Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Eletriptan.
Where does this information come from?
All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.
Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.